Cellular and functional aspects of the renal kallikrein system in health and disease

Biological Research

Volumn 31, Issue 3, 1998, Pages 305-322

  Vio, Carlos P ^a   Olavarría, Verónica ^a   González, Claudia ^a   Nazal, Leyla ^a   Córdova, Marcela ^a   Balestrini, Claudia ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Angiotensin I converting enzyme; Aprotinin; Bradykinin receptors; Cyclooxygenases; Hypertension; Kallikrein

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; KALLIKREIN; KININ; KININASE; KININOGEN;

DIABETES MELLITUS; DIURESIS; GLOMERULUS; HYPERTENSION; KALLIKREIN KININ SYSTEM; KIDNEY BLOOD FLOW; NEPHRON; PATHOPHYSIOLOGY; REVIEW; SALURESIS;

ANIMALS; HUMANS; HYPERTENSION; KALLIKREIN-KININ SYSTEM; KIDNEY; KIDNEY TUBULES;

GLOMERULUS;

EID: 0031692940     PISSN: 07169760     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (127)

1. ABE M, NAKAMURA F, TAN F, DEDDISH PA, COLLEY KJ, BECKER RP, SKIDGEL RA, ERDÖS EG (1995) Expression of rat kallikrein and epithelial polarity in transfected Madin-Darby canine kidney cells. Hypertension 26: 891-898
2. ALBERTINI R, VARGAS L, OLIVERI P, PARDO F, PAREDES MC (1987) Sympathetic nervous system mediates urinary kallikrein excretion in conscious rats. Clin Exp Pharmacol Physiol 14: 291-301
3. ALFIE ME, SIGMON DH, POMPOSIELLO SI, CARRETERO OA (1997) Effect of high salt intake in mutant mice lacking bradykinin-B2 receptors. Hypertension 29: 483-487
4. BARAJAS L, POWERS K, CARRETERO OA, SCICLI AG, INAGAMI T (1986) Immunocytochemical localization of renin and kallikrein in the rat renal cortex. Kidney Intl 29: 965-970
5. BELLINI C, FERRI C, CARLOMAGNO A, NECOZIONE S, LEPORE AR, DESIDERI G, SANTUCCI A (1996) Impaired inactive to active kallikrein conversion in human salt-sensitive hypertension. J Am Soc Nephrol 7: 2565-2577
6. BHOOLA KD, FIGUEROA CD, WORTHY K (1992) Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 44: 1-80
7. BONNER G (1997) The role of kinins in the antihypertensive and cardioprotective effects of ACE inhibitors. Drugs 54 (suppl 15): 23-30
8. BONNER G, THIEVEN B, RUTTEN H, KRONE W (1993) Renal kallikrein is a determinant of salt sensitivity. J Hypertens 11: S210-S211
9. BONVALET JP, PRADELLES P, FARMAN N (1987) Segmental synthesis and actions of prostaglandins along the nephron. Am J Physiol 253: F377-F387
10. BORIC MP, CORTHORN J, SILVA R, ROBLERO JS (1990) Polarity of kallikrein release and activation in perfused ral kidneys. Am J Physiol 259: F752-F757
11. BRANDAN E, ROJAS M, LOYARTE N, ZAMBRANO F (1982) Golgi complex function in the excretion of renal kallikrein. Proc Soc Exp Biol Med 171: 221-231
12. BROSNIHAN KB, LI P, TALLANT EA, FERRARIO CM (1998) Angiotensin-(1-7): A novel vasodilator of the coronary circulation. Biol Res 31: 000-000
13. CAMPBELL DJ, KLADIS A, DUNCAN AM (1993) Bradykinin peptides in kidney, blood and other tissues of the rat. Hypertension 211: 55-165
14. CAMPBELL DJ, KLADIS A, DUNCAN AM (1994) Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension 23: 439-449
15. CARRETERO OA, BEIERWALTES WH (1984) Effect of glandular kallikrein, kinins and aprotinin (a serine protease inhibitor) on renin release. J Hypertens 2: 125-130
16. CHAO J, ZHANG JJ, LIN KF, CHAO L (1998) Human kallikrein gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in Dahl salt-sensitive rats. Hum Gene Ther 9: 21-31
17. CHEN LM, SONG Q, CHAO L, CHAO J (1995) Cellular localization of tissue kallikrein and kallistatin mRNAs in human kidney. Kidney Intl 48: 690-697
18. CLEMENTS JA (1998) Current perspectives on the molecular biology of the renal tissue kallikrein gene and the related tissue kallikrein gene family. Biol Res 31: 151-159
19. CONCHON S, MONNOT C, TEUSCH B, CORVOL, CLAUSER E (1994) Internalization of the rat AT and AT receptors: pharmacological and functional requirements. FEBS Lett 349: 365-370
20. COSTEROUSSE O, ALLEGRINI J, HUANG W, ALHENC-GELAS F (1998) Angiotensin I-converting enzyme (kininase II) in cardiovascular and renal regulations and diseases. Biol Res 31: 161-167
21. CROXATTO HR, SAN MARTIN M (1970) Kallikrein-like activity in the urine of renal hypertensive rats. Experientia 26: 1216
22. DAMAS J (1996) The Brown Norway rats and the kinin system. Peptides 17: 859-872
23. DAVIS R, WHITTINGTON R (1995) Aprotinin. A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery. Drugs 49: 954-983
24. DINCHUK JE, CAR BD, FOCH RJ, JOHNSTON JJ, JAFFEE BD, COVINGTON MB, CONTEL NR, ENG VM, COLLINS RJ, CZERNIAK PM, STEWARD AG, TRZASKOS JM (1995) Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 378: 406-409
25. EL-DAHR SS, CHAO J (1992) Spatial and temporal expression of kallikrein and its mRNA during nephron maturation. Am J Physiol 262: F705-F711
26. ERDÖS EG (1990) Angiotensin I converting enzyme and the changes in our concepts through the years. Hypertension 16: 363-370
27. ERDÖS EG, SKIDGEL RA (1987) The angiotensin I-converting enzyme. Lab Invest 56: 345-348
28. ERDÖS EG, SKIDGEL RA (1989) Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB J 3: 145-151
29. ERICSEN EF, RICHELSEN BP, GESSER BP, JACOBSEN NO, STENGARD-PEDERSEN K (1987) Prostaglandin E2 receptors in the rat kidney: biochemical characterization and localization. Kidney Intl 32: 181-186
30. ESTHER CR Jr, HOWARD TE, MARINO EM, GODDARD JM, CAPECCHI M, BERNSTEIN KE (1996) Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab Invest 74: 953-965
31. FERREIRA SH (1965) Bradykinin potentiating factor (BPF) present in the venom of Bothrops jararaca. Br J Pharmacol 24: 163-169
32. FERRERI NR, McGIFF JC, VIO CP (1998) Cyclooxygenase is expressed functionally in the renal thick ascending limb via angiotensin II stimulation of tumor necrosis factor a. In: BOTTING RM, VANE JR (eds) Clinical Benefits of Selective COX-2 Inhibitors. London: William Harvey Res Conf. (In press)
33. FERRERI NR, ESCALANTE BA, ZHAO Y, AN SJ, McGIFF JC (1998) Angiotensin H induces TNF production by the thick ascending limb: functional implications. Am J Physiol 274: F148-F155
34. FERRI C, BELLINI C, CARLOMAGNO A, PERRONE A, SANTUCCI A (1994) Urinary kallikrein and salt sensitivity in essential hypertensive males. Kidney Intl 46: 780-788
35. FERRI C, BELLINI C, CARLOMAGNO A, DESIDERI G, SANTUCCI A (1996) Active kallikrein response to changes in sodium-chloride intake in essential hypertensive patients. J Am Soc Nephrol 7: 443-453
36. FIELD MJ, GIEBISCH GJ (1985) Hormonal control of renal potassium excretion. Kidney Intl 27: 379-387
37. FIGUEROA CD, CAORSI I, SUBIABRE J, VIO CP (1984) Immunoreactive kallikrein localization in the rat kidney: An immuno-electron microscopic study. J Histochem Cytochem 32: 117-121
38. FIGUEROA CD, GONZALEZ CB, GRIGORIEV S, ABD-ALLA S, HAASEMANN M, JARNAGIN K, MULLER-ESTERL W (1995) Probing for the bradykinin B2 receptor in the rat kidney by anti-peptide and anti-ligand antibodies. J Histochem Cytochem 43: 137-148
39. FIGUEROA CD, MacIVER AG, MacKENZIE JC, BHOOLA KD (1988) Localisation of immunoreactive kininogen and tissue kallikrein in the human nephron. Histochemistry 89: 437-442
40. FIGUEROA CD, MULLER-ESTERL W (1998) Autoradiographic and immunological techniques to analyse kinin receptor distribution in rat and human tissues. Biol Res 31: 175-187
41. FRITZ H, FINK E, TRUSCHEIT E (1979) Kallikrein inhibitors. Fed Proc 38: 2753-2759
42. FULLER PJ, CLEMENTS JA, NIKOLAIDIS I, HIWATARI M, FUNDER JW (1986) Expression of the renal kallikrein gene in mineralocorticoid-treated and genetically hypertensive rats. J Hypertens 4: 427-432
43. FULTON D, McGIFF JC, QUILLEY J (1992) Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney. Br J Pharmacol 107: 722-725
44. GALLAGHER AM, YU H, PRINTZ MP (1998) Bradykinin-induced reductions in collagen gene expression involve prostacyclin. Hypertension 32: 84-88
45. GAVRAS I (1992) Bradykinin-mediated effects of ACE inhibition. Kidney Intl 42: 1020-1029
46. GIROLAMI JP, BASCANDS JL, VALET P, PECGER C, CABOS G (1990) Beta-1 adrenergic inhibition of kallikrein release from rat kidney cortical slices. Am J Physiol 258: F1425-F1431
47. GOMEZ RA, PUPILLI C, EVERETT A (1991) Molecular and cellular aspects of rcnin during kidney ontogeny. Pediatr Nephrol 5: 80-87
48. GUDER WG, HALLBACK J, FINK E, KAISSLING B, WIRTHENSON G (1987) Kallikrein (kininogenase) in the mouse nephron: effect of dietary potassium. Hoppe-Seyler's Biol Chem 368: 637-645
49. HACKENTHAL E, PAUL M, GANTEN D, TAUGNER R (1990) Morphology, physiology, and molecular biology of renin secretion. Physiol Rev 70: 1067-1116
50. HERMANN A, BRAUN A, FIGUEROA CD, MULLER-ESTERL W, FRITZ H, REHBOCK J (1996) Expression and cellular localization of kininogens in the human kidney. Kidney Intl 50: 79-84
51. HORWITZ D, MARGOLIUS HS, KEISER HR (1978) Effects of dietary potassium and race on urinary excretion of kallikrein and aldosterone in man. J Clin Endocr Metab 47: 296-299
52. HUANG WC, JACKSON C, NAVAR G (1985) Nephron responses to converting enzyme inhibition in non-clipped kidney of Goldblatt hypertensive rat at normotensive pressures. Kidney Intl 28: 128-134
53. HUNT SC, HASSTED SJ, WU LL, WILLIAMS RR (1993) A gene-environment interaction between inferred kallikrein genotype and potassium. Hypertension 22: 161-168
54. JAFFA AA, MILLER BS, ROSENZWEIG SA, NAIDU PS, VELARDE V, MAYFIELD RK (1997) Bradykinin induces tubulin phosphorylation and nuclear translocation of MAP kinase in mesangial cells. Am J Physiol 273: F916-F924
55. JAFFA AA, VIO CP, SILVA RH, VAVREK RJ, STEWART JM, RUST PF, MAYFIELD RK (1992) Evidence for renal kinins as mediators of amino acid-induced hyperperfusion and hyperfiltration in the rat. J Clin Invest 89: 1460-1468
56. JASPARD E, WEI L, ALHENC-GELAS F (1993) Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). J Biol Chem 268: 9496-9503
57. JORGENSEN PL (1986) Structure, function and regulation of Na,K-ATPase in the kidney. Kidney Intl 29: 10-20
58. JUST M, TOROK P, HABERMANN E (1973) Interaction of Trasylol with subcellular structures of the kidney. In: HABERLAND GL, ROHEN JW (eds) Kininogenases, Kallikrein. Stuttgart: FK Schattauer Verlag, pp 123-127
59. KARPPANEN H, MERVAALA E (1996) Adherence to and population impact of non-pharmacological and pharmacological antihypertensive therapy. J Hum Hypertens 10(suppl 1): S57-S61
60. KASHGARIAN M, BIEMESDERFER D, CAPLAN M, FORBUSH B (1985) Monoclonal antibody to Na,K-ATPase: immunocytochemical localization along nephron segments. Kidney Intl 28: 899-913
61. KATORI M, MAJIMA M, HAYASHI I (1998) Crucial suppressive role of renal kallikrein-kinin system in development of salt-sensitive hypertension. Biol Res 31: 143-149
62. KAUFMAN JS, HAMBURGER RJ (1996) Potassium transport in the connecting tubule. Miner Electrol Metab 22: 242-247
63. KELLER P, SIMONS K (1997) Post-Golgi biosynthetic trafficking. J Cell Sci 110: 3001-3009
64. KRIZ W, BANKIR L (1988) A standard nomenclature for structures of the kidney. Kidney Intl 33: 1-7
65. KRIZ W, KAISSLING B (1992) Structural organization of the mammalian kidney. In: SELDIN DW, GIEBISH G (eds) The Kidney: Physiology and Pathophysiology. New York: Raven Pr. pp 707-777
66. KUJUBU DA, FLETCHER BS, VARNUM BC, LIM RW, HERSCHMAN HR (1991) TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/ cyclooxygenase homologue. J Biol Chem 266: 12866-12872
67. LAHERA V, SALOM MG, FIKSEN-OLSEN MJ, ROMERO JC (1991) Mediatory role of endothelium-derived nitric oxide in renal vasodilator and excretory effects of bradykinin. Am J Hypertens 4: 260-262
68. MacGREGOR GA, SMITH SJ, MARKANDU ND, BANKS RA, SAGNELLA GA (1982) Moderate potassium supplementation in essential hypertension. Lancet 2 (8298): 567-570
69. MADEDDU P, VARONI MV, DEMONTIS MP, CHAO J, SIMSON JA, GLORIOSO N, ANANIA V (1997) Kallikrein-kinin system and blood pressure sensitivity to salt. Hypertension 29: 471-477
70. MADEDDU P, VARONI MV, PALOMBA D, EMANUELI C, DEMONTIS MP, GLORIOSO N, DESSI-FULGHERI P, SARZANI R, ANANIA V (1997) Cardiovascular phenotype of a mouse strain with disruption of bradykinin B2-receptor gene. Circulation 96: 3570-3578
71. MAJIMA M, YOSHIDA O, MIHARA H, MUTO T, MIZOGAMI S, KURIBAYASHI Y, KATORI M, OHISHI S (1993) High sensitivity to salt in kininogen-deficient Brown Norway Katholiek rats. Hypertension 22: 705-714
72. MAJIMA M, MIZOGAMI S, KURIBAYASHI Y, KATORI M, OH-ISHI S (1994) Hypertension induced by a non-pressor dose of angiotensin II in kininogen-deficient rats. Hypertension 24: 111-119
73. MARCHETTI J, IMBERT-TEBOUL M, ALHENC-GELAS F, ALLEGRINI J, MENARD J, MOREL F (1984) Kallikrein along the rabbit microdissected nephron: a micromethod for its measurement. Effect of adrenalectomy and DOCA-treatment. Pflügers Arch 401: 27-33
74. MARGOLIUS HS (1998) Kallikreins, kinins and cardiovascular diseases: A short review. Biol Res 31: 135-141
75. MATTSON DL, COWLEY AW (1993) Kinin actions on renal papillary blood flow and sodium excretion. Hypertension 21: 961-965
76. 2 bradykinin receptor. Proc Natl Acad Sci USA 88: 7724-7728
77. MENNITT PA, WADE JB, ECELBARGER CA, PALMER LG, FRINDT G (1997) Localization of ROMK channels in the rat kidney. J Am Soc Nephrol 8: 1823-1830
78. MISUMI J, ALHENC-GELAS F, MARRE M, MARCHETTI J, CORVOL P, MENARD J (1983) Regulation of kallikrein and renin release by the isolated perfused rat kidney. Kidney Intl 24: 58-65
79. MORHAM SG, LAGENBACH R, LAFTIN LD, TIANO HF, VOULOUMANOS N, JENETTE JC, MAHLER JF, KLUCKMAN KD, LEDFORD A, LEE CA, SMITHIES O (1995) Prostaglandin synthase 2 gene disruption causes several renal pathology in the mouse. Cell 83: 473-482
80. MUKAI H, FITZGIBBON WR, PLOTH DW, MARGOLIUS HS (1998) Effect of chronic bradykinin B2 receptor blockade on blood pressure of conscious Dahl salt-resistant rats. Br J Pharmacol 124: 197-205
81. MULLER-ESTERL W (1989) Kininogens, kinins and kinships. Thromb Hemost 61: 2-6
82. NASJLETTI A, McGIFF JC, COLINA-CHOURIO J (1978) Interrelation of the renal kallikrein kinin system and renal prostaglandins in the conscious rat. Circ Res 43: 799-806
83. NAVAR LG, VON THUN AM, ZOU L, EL-DAHR SS, MITCHELL KD (1995) Enhancement of intrarenal angiotensin II levels in 2 kidney 1 clip and angiotensin II induced hypertension. Blood Press Suppl 2: 88-92
84. NI A, CHAO L, CHAO J (1998) Transcription factor nuclear factor kappaB regulates the inducible expression of the human B1 receptor gene in inflammation. J Biol Chem 273: 2784-2791
85. NOLLY H, NOLLY A (1998) Release of endothelial-derived kallikrein, kininogen and kinins. Biol Res 31: 000-000
86. O'NEILL GP, FORD-HUTCHINSON AW (1993) Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett 330: 156-160
87. PIZARD A, MARCHETTI J, ALLEGRINI J, ALHENC-GELAS F, RAJERISON RM (1998) Negative cooperativity in the human bradykinin B2 receptor. J Biol Chem 273: 1309-1315
88. PLOTH DW (1983) Angiotensin-dependent renal mechanisms in two-kidney, one-clip renal vascular hypertension. Am J Physiol 245: F131-F141
89. PROUD D, KNEPPER MA, PISANO JJ (1982) Distribution of immunoreactive kallikrein along the rat nephron. Am J Physiol 244: F510-F515
90. PROUD D, NAKAMURA S, CARONE FA, HERRING PL, KAWAMURA M, INAGAMI T, PISANO JJ (1984) Kallikrein-kinin and renin-angiotensin systems in rat renal lymph. Kidney Intl 25: 880-885
91. PROUD D, PERKINS M, PIERCE JV, YATES KN, HIGHET PF, HERRING PL, MANGKORNKANOK/MARK M, BAHU R, CARONE F, PISANO JJ (1981) Characterization and localization of human renal kininogen. J Biol Chem 256: 10634-10639
92. RECABARREN M, BALESTRINI C, CESPEDES C, VIO CP (1997) Postnatal development of cyclooxygenase-2 and regulation by endogenous glucocorticoids. 40th Annu Meet Soc Biol Chile. Notic Biol 5 (4): 81 (Abstract)
93. REGOLI D, BARABE J (1980) Pharmacology of bradykinin and related kinins. Pharmacol Rev 32: 1-46
94. ROBLERO J, CROXATTO H, GARCIA R, CORTHORN J, DE VITO E (1976) Kallikrein-like activity in perfusates and urine of isolated rat kidneys. Am J Physiol 231: 1383-1389
95. RUIZ-ORTEGA M, EGIDO J (1997) Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney Intl 52: 1497-1510
96. SALVEMINI D, MISKO TP, MASFERRER JL, SEIBERT K, CURRIE MG, NEEDLEMAN P (1993) Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90: 7240-7244
97. SCHANSTRA JP, BATAILLE E, MARIN-CASTANO ME, BARASCUD Y, HIRTS C, PESQUERO JP, PECHER C, GAUTHIER F, GIROLAMI JP, BASCANDS JL (1998) The B1-agonist [des-Arg10]-kallidin activates transcription factor NF-kappaB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts. J Clin Invest 101: 2080-2091
98. SCHMAIER AH (1998) Plasma contact activation: A revised hypothesis. Biol Res 31: 251-262
99. SCHNERMANN J, BRIGGS JP, SCHUBERT G, MARIN-GREZ M (1984) Opposing effects of captopril and aprotinin on tubuloglomerular feedback response. Am J Physiol 247: F912-F918
100. SCHREMMER-DANNINGER E, TOEPFER-PETERSEN E, FRITZ H, ROSCHER AA (1998) Bradykinin-induced tyrosine phosphorylation of proteins in cultured human keratinocytes. Biol Res 31: 189-198
101. SEALEY JE, ATLAS SA, LARAGH JH, OZA NB, RYAN JW (1978) Human urinary kallikrein converts inactive to active renin an is a possible physiological activator of renin. Nature 275: 144-145
102. SIBONY M, GASC JM, SOUBRIER F, ALHENC-GELAS F, CORVOL F (1993) Gene expression and tissue localization of the two isoforms of angiotensin I converting enzyme. Hypertension 21: 827-835
103. SIRAGY HM (1993) Evidence that intrarenal bradykinin plays a role in regulation of renal function. Am J Physiol 265: E648-E654
104. SIRAGY HM, IBRAHIM M, JAFFA AA, MAYFIELD R, MARGOLIUS HS (1994) Rat renal interstitial bradykinin, prostaglandin E2, and cyclic guanosine 3′,5′-monophosphate. Effects of altered sodium intake. Hypertension 23: 1068-1070
105. SIRAGY HM, JAFFA AA, MARGOLIUS HS (1997) Bradykinin B2 receptor modulates renal prostaglandin E2 and nitric oxide. Hypertension 29: 757-762
106. SIRAGY HM, JAFFA AA, MARGOLIUS HS (1993) Stimulation of renal interstitial bradykinin by sodium depletion. Am J Hypertens 6: 863-866
107. SIRAGY HM, JAFFA AA, MARGOLIUS HS, CAREY RM (1996) Renin-angiotensin system modulates renal bradykinin production. Am J Physiol 271: R1090-R1095
108. SMITH WL, BELL TG (1978) Immunohistochermcal localization of the prostaglandin-forming cyclooxygenase in renal cortex. Am J Physiol 235: F451-F457
109. TREASURE J, PLOTH D (1983) Role of dietary potassium in the treatment of hypertension. Hypertension 5: 864-872
110. VALDÉS G, VIO CP, MONTERO J, AVENDAÑO R (1991) Potassium supplementation lowers blood pressure and increases kallikrein in essential hypertensives. J Hum Hypertens 5: 91-96
111. VELARDE V, HUMPHREYS J, FIGUEROA CD, VIO CP (1995) Postnatal maturation of kallikrein-producing cells (connecting tubule cells) in the rat kidney. A morphometric and immunohistochemical study. Anat Embryol 192: 399-406
112. VIO CP, CESPEDES C, GALLARDO P, MASFERRER JL (1997) Renal Identification of cyclooxygenase-2 in a subset of thick ascending limb cells. Hypertension 30: 687-692
113. VIO CP, CHURCHILL L, RABITO SF, TERRAGNO A, CARRETERO OA, TERRAGNO NA (1983) Renal kallikrein in venous effluent of filtering and non-filtering isolated kidneys. Adv Exp Med Biol 156: 897-907
114. VIO CP, CORDOVA M, ALHENC-GELAS F (1997) Increased angiotensin I-converting enzyme in epithelial, endothelial and interstitial cells in hypertensive kidneys. Hypertension 29: A847
115. VIO CP, ERLICH R, CLEMENTS J (1997) Cellular localization of renal kallikrein with specific rKLK1 gene probes and antibodies. Hypertension 29: A872
116. VIO CP, FIGUEROA CD (1987) Evidence for a stimulatory effect of high potassium diet on renal kallikrein. Kidney Intl 31: 1327-1334
117. VIO CP, FIGUEROA CD (1985) Subcellular localization of renal kallikrein by structural immunocytochemistry. Kidney Intl 28: 36-42
118. VIO CP, FIGUEROA CD, CAORSI I (1988) Anatomical relationship between kallikrein-containing tubules and the juxtaglomerular apparatus in the human kidney. Am J Hypertens 1: 269-271
119. VIO CP, LOYOLA S, VELARDE V (1992) Localization of components of the kallikrein-kinin system in the kidney: Relation to renal function. Hypertension 19: 10-16
120. VIO CP, OBSTREICHER E, OLAVARRIA V, VELARDE V, MAYFIELD RK, JAFFA AA (1998) Cellular distribution of exogenous aprotinin in the rat kidney. Biol Chem 379 (In press)
121. VIO CP, VELARDE V, MULLER-ESTERL W (1996) Cellular distribution and fate of the bradykinin antagonist (HOE 140) in the rat kidney: Colocalization with the bradykinin B2 receptor. Immunopharmacology 33: 146-150
122. WALD H, SCHERZER P, RUBINGER D, POPOVTZER M (1990) Effect of indomethacin in vivo and PGE2 in vitro on MTAL Na-K-ATPase on the rat kidney. Pflügers Arch 415: 648-650
123. WARD PE, GEDNEY CD, DOWBEN RM, ERDÖS EG (1975) Activation of membrane-bound kallikrein and kininase. Biochem J 151: 755-758
124. WEBER KT, BRILLA CG (1991) Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 83: 1849-1865
125. XIONG W, CHAO L, CHAO J (1989) Renal kallikrein mRNA localization by in situ hybridization. Kidney Intl 35: 1324-1329
126. YAMADA K, ERDÖS EG (1982) Kallikrein and prekallikrein of the isolated basolateral membrane of rat kidney. Kidney Intl 22: 331-337
127. + uptake by rabbit inner medullary collecting duct cells. Am J Physiol 258: F1584-F1591